Literature DB >> 27527749

Hospital admissions for viral meningitis in children in England over five decades: a population-based observational study.

Natalie G Martin1, Mildred A Iro2, Manish Sadarangani2, Raphael Goldacre3, Andrew J Pollard2, Michael J Goldacre3.   

Abstract

BACKGROUND: A substantial reduction in bacterial meningitis has occurred in the UK following successful implementation of immunisation programmes. Most childhood meningitis in developed countries is now caused by viruses. Long-term trends in paediatric viral meningitis in England have not previously been reported. The objective of this study is to report on epidemiological trends over time in childhood viral meningitis in England.
METHODS: In this population-based observational study, we used routinely collected hospital discharge records from English National Health Service hospitals from 1968-2011 to analyse annual age-specific admission rates for viral meningitis, including specific viral aetiologies, in children younger than 15 years.
FINDINGS: We analysed hospital discharge records from Jan 1, 1968, to Dec 31, 2011. Hospital admission rates for viral meningitis from Jan 1, 1968, to Dec 31, 1985, varied annually, with a mean of 13·5 admissions per 100 000 children aged less than 15 years, per year (95% CI 13·0-14·0). Admission rates declined during the late 1980s, and the mean number of admissions from 1989-2011 was 5·2 per 100 000 per year (5·1-5·3). This decrease was entirely in children aged 1-14 years. Admission rates for infants aged less than 1 year increased since 2005, to 70·0 per 100 000 (63·7-76·2) in 2011, which was driven by an increase in admission of infants aged 90 days or less. In 1968-85, the majority of cases in children were in those aged 1-14 years (22 150 [89%] of 24 920 admissions). In 2007-11, 1716 (72%) of 2382 cases were in infants. Admissions for mumps-related meningitis almost disappeared following introduction of the measles-mumps-rubella (MMR) vaccine in 1988. Admissions with a specified viral aetiology have increased since 2000.
INTERPRETATION: Trends in viral meningitis admissions have changed substantially over the past 50 years, and probably reflect the impact of the MMR vaccine programme and the use of more sensitive diagnostic techniques. FUNDING: None.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27527749     DOI: 10.1016/S1473-3099(16)30201-8

Source DB:  PubMed          Journal:  Lancet Infect Dis        ISSN: 1473-3099            Impact factor:   25.071


  15 in total

1.  Age-specific application of neutrophil-to-lymphocyte ratio in meningitis: a nationwide study.

Authors:  A-F A Mentis; M A Kyprianou; G Tzanakaki
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-03-24       Impact factor: 3.267

2.  Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands.

Authors:  M van Wijhe; A D Tulen; H Korthals Altes; S A McDonald; H E de Melker; M J Postma; J Wallinga
Journal:  Epidemiol Infect       Date:  2018-03-14       Impact factor: 4.434

3.  The seasonality of nonpolio enteroviruses in the United States: Patterns and drivers.

Authors:  Margarita Pons-Salort; M Steven Oberste; Mark A Pallansch; Glen R Abedi; Saki Takahashi; Bryan T Grenfell; Nicholas C Grassly
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-05       Impact factor: 11.205

4.  Enteroviral and herpes simplex virus central nervous system infections in infants < 90 days old: a Paediatric Investigators' Collaborative Network on Infections in Canada (PICNIC) study.

Authors:  Dara Petel; Michelle Barton; Christian Renaud; Lynda Ouchenir; Jason Brophy; Jennifer Bowes; Sarah Khan; Ari Bitnun; Jane McDonald; Andrée-Anne Boisvert; Joseph Ting; Ashley Roberts; Joan L Robinson
Journal:  BMC Pediatr       Date:  2020-05-26       Impact factor: 2.125

5.  Incidence, aetiology, and sequelae of viral meningitis in UK adults: a multicentre prospective observational cohort study.

Authors:  Fiona McGill; Michael J Griffiths; Laura J Bonnett; Anna Maria Geretti; Benedict D Michael; Nicholas J Beeching; David McKee; Paula Scarlett; Ian J Hart; Kenneth J Mutton; Agam Jung; Guleed Adan; Alison Gummery; Wan Aliaa Wan Sulaiman; Katherine Ennis; Antony P Martin; Alan Haycox; Alastair Miller; Tom Solomon
Journal:  Lancet Infect Dis       Date:  2018-06-29       Impact factor: 25.071

6.  Clinical characteristics and molecular epidemiology of children with meningitis in Tehran, Iran: a prospective study.

Authors:  A Pormohammad; S Lashkarbolouki; T Azimi; P Gholizadeh; N Bostanghadiri; H Safari; S Armin; N Mohtavinejad; F Fallah
Journal:  New Microbes New Infect       Date:  2019-08-29

7.  A review of a 13-month period of FilmArray Meningitis/Encephalitis panel implementation as a first-line diagnosis tool at a university hospital.

Authors:  Agathe Boudet; Alix Pantel; Marie-Josée Carles; Hélène Boclé; Sylvie Charachon; Cécilia Enault; Robin Stéphan; Lucile Cadot; Jean-Philippe Lavigne; Hélène Marchandin
Journal:  PLoS One       Date:  2019-10-24       Impact factor: 3.240

8.  Serotype-specific immunity explains the incidence of diseases caused by human enteroviruses.

Authors:  Margarita Pons-Salort; Nicholas C Grassly
Journal:  Science       Date:  2018-08-24       Impact factor: 47.728

9.  Epidemic dynamics, interactions and predictability of enteroviruses associated with hand, foot and mouth disease in Japan.

Authors:  Saki Takahashi; C Jessica E Metcalf; Yuzo Arima; Tsuguto Fujimoto; Hiroyuki Shimizu; H Rogier van Doorn; Tan Le Van; Yoke-Fun Chan; Jeremy J Farrar; Kazunori Oishi; Bryan T Grenfell
Journal:  J R Soc Interface       Date:  2018-09-12       Impact factor: 4.118

10.  Assessment of blood enterovirus PCR testing in paediatric populations with fever without source, sepsis-like disease, or suspected meningitis: a prospective, multicentre, observational cohort study.

Authors:  Jérémy Lafolie; André Labbé; Anne Sophie L'Honneur; Fouad Madhi; Bruno Pereira; Marion Decobert; Marie Noelle Adam; François Gouraud; Frédéric Faibis; Francois Arditty; Stéphanie Marque-Juillet; Marie Aline Guitteny; Gisele Lagathu; Matthieu Verdan; Flore Rozenberg; Audrey Mirand; Hélène Peigue-Lafeuille; Cécile Henquell; Jean-Luc Bailly; Christine Archimbaud
Journal:  Lancet Infect Dis       Date:  2018-10-30       Impact factor: 25.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.